Find last week’s questions here, and to get Atlantic Trivia in your inbox every day, sign up for The Atlantic Daily. In the ...
CRISPR, the gene-editing technology which won its creators the 2020 Nobel Prize for Chemistry, is most well-known for its ...
This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.
Nobel Prize laureate Professor Ardem Patapoutian, whose pioneering work revealed how our bodies sense touch and pressure - essential for movement, pain perception, and survival - delivered the 2025 ...
Explore Intellia Therapeutics, Inc.'s outlook after Phase 3 trial concerns. See how FDA decisions may impact CRISPR therapy ...
When UC Berkeley biochemist Jennifer Doudna first began studying how bacteria fight virus infections, she had no idea it ...
It might be time to look a bit off the beaten path, at names that can stand up to any AI-stock-led correction.
A Bay Area biochemist has launched a new company to further research on gene editing on human embryos. Lucas Harrington said the research will focus on using the technology to prevent genetic disease ...
JUPITER, Fla. and DUBLIN, Nov. 10, 2025 (GLOBE NEWSWIRE) -- ERS Genomics Limited (‘ERS’), the CRISPR licensing company, and Dyadic Applied BioSolutions, a global biotechnology company producing ...
A spinout from the lab of Nobel laureate Jennifer Doudna has raised $82 million to create drugs that, with a single infusion, can turn patients’ immune cells into cancer- and autoimmune ...
Hosted on MSN
3 Monster Stocks to Hold for the Next 10 Years
Gene editing is now possible, and the underlying potential of the science is enormous -- just ask CRISPR Therapeutics. Share prices of electric vehicle maker BYD have struggled of late, but its ...
Connor Tou arrived at University of California, Berkeley, in 2016 with dreams of making biofuel-belching microbes. In his first week, Tou emailed a half-dozen synthetic biology professors about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results